The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.
Abstract
PURPOSE: This study was undertaken to define prognostically favorable and unfavorable subgroups of node-negative breast carcinoma patients by employing conventional pathologic data. PATIENTS AND METHODS: Seven hundred sixty-seven women with T1N0M0/T2N0M0 breast carcinoma treated consecutively from 1964 through 1970 by modified or radical mastectomy without systemic adjuvant therapy were analyzed at a median follow-up duration of 18 years. RESULTS: Size and histologic type of the carcinoma were crucial discriminants of prognosis. We defined a prognostically favorable group of 219 patients (29%) with infiltrating duct or lobular carcinoma < or = 1.0 cm in diameter or special tumor types < or = 3.0 cm. This group had a relapse-free survival rate of 91% at 10 years and 87% at 20 years. The less favorable group (548 patients, 71%) with infiltrating duct or lobular carcinoma greater than 1.0 cm and special tumor types greater than 3.0 cm had relapse-free survival rates of 73% and 68% at 10 and 20 years, respectively. The frequency of nonmammary malignant neoplasms (NMMN) was similar to that of contralateral carcinoma. Deaths due to NMMN were seven times more frequent than deaths due to contralateral carcinoma. CONCLUSION: Nearly 30% of these node-negative patients, identified on the basis of tumor size and type, had an extremely favorable prognosis. There is insufficient evidence to warrant the routine use of adjuvant therapy in this group unless new forms of treatment prove to be less toxic and/or more effective in enhancing relapse-free survival. Early detection of NMMN should be an important part of the follow-up of node-negative breast carcinoma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reyment, R. A., & Huxley, J. S. (1994) · Biometrics · doi:10.2307/2532815 · Cited by 2,090
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen, P. R., Groshen, S., Saigo, P. E., Kinne, D. W., & Hellman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.3.355 · Cited by 415
Self-citationRosen, P. P., Groshen, S., Saigo, P. E., Kinne, D. W., & Hellman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1239 · Cited by 355
Self-citationPrognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer
Elledge, R. M., & McGuire, W. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001221 · Cited by 257
Insulin-like growth factors in human breast cancer
Ellis, M. J., Jenkins, S., Hanfelt, J., Redington, M. E., Taylor, M., Leek, R., Siddle, K., & Harris, A. L. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5195-9_21 · Cited by 120
Forty-five years of cancer incidence in Connecticut: 1935-79.
Heston, J. F., Cusano, M. M., & Young, J. L. (1986) · PubMed · Cited by 102
Pedersen, L., Holck, S., Schiødt, T., et al. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01805979 · Cited by 52
Cited by
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Prognostic and Predictive Factors in Early-Stage Breast Cancer
Cianfrocca, M., & Goldstein, L. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-606 · Cited by 637
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Tumor Heterogeneity in Breast Cancer
Turashvili, G., & Brogi, E. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00227 · Cited by 561
Treatment of early-stage breast cancer
Hurd, T. C., Edge, S. B., Kahlenberg, M. S., Stomper, P. C., Proulx, G. M., Schwartz, G., Khatri, V., & Winston, J. S. (1999) · Current Problems in Cancer · doi:10.1016/s0147-0272(99)90004-1 · Cited by 477
Metadata
- Authors
- Rosen, P. P., Groshen, S., Kinne, D. W., & Norton, L.
- Venue
- Journal of Clinical Oncology
- Published
- 1993-11
- Volume
- 11
- Issue
- 11
- Pages
- 2090-2100
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136270722
- Cited by
- 295
- References
- 7
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. https://app.cochat.ai/papers/10.1200/jco.1993.11.11.2090
- The paper
- Rosen, P. P., Groshen, S., Kinne, D. W., & Norton, L. (1993). Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1993.11.11.2090
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.